Drug Detail:Glatiramer (injection) (Glatiramer (injection) [ gla-tir-a-mer ])
Drug Class: Other immunostimulants
Usual Adult Dose for Multiple Sclerosis
20 mg subcutaneously once a day or 40 mg subcutaneously 3 times a week
Comments:
- For the 3 times a week dosage regimen, each dose must be separated by at least 48 hours.
- Length of treatment should be individualized.
Approved indication: For the treatment of patients with relapsing forms of multiple sclerosis
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Precautions
Safety and efficacy have not been established in patients younger than 18 years.
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
General:
- Because this drug can modify immune response, it could possibly interfere with useful immune function.
- Injection sites should be rotated.
- This drug should only be administered subcutaneously, not IV or IM.
- The initiation of treatment should be supervised by a neurologist or a physician experienced in the treatment of MS.
Frequently asked questions
- What happens if an MS patient stops taking Copaxone?
- Where and how should Copaxone be injected?
- How long does it take for Copaxone to be effective?
- How long can you take Copaxone?
- How does Copaxone work as treatment for multiple sclerosis?